WHO Drug Information Vol. 17, No. 3, 2003
(2003; 85 pages) View the PDF document
Table of Contents
Open this folder and view contentsRational Use of Drugs
Open this folder and view contentsSafety and Efficacy Issues
Open this folder and view contentsIndividual Drugs
Open this folder and view contentsAspects of Quality Assurance
Open this folder and view contentsConsultation Document
Open this folder and view contentsRegulatory and Safety Action
Open this folder and view contentsRegulatory Challenges
Close this folderATC/DDD Classification
View the documentFinal List
View the documentTemporary list
View the documentProposed International Nonproprietary Names: List 89
View the documentAnnex 1 - Procedure for the selection of recommended international nonproprietary names for pharmaceutical substances*
View the documentAnnex 2 - General principles for guidance in devising international nonproprietary names for pharmaceutical substances*
View the documentAnnexe 1 - Procédure a suivre en vue du choix de dénominations communes internationales recommandées pour les substances pharmaceutiques
View the documentAnnexe 2 - Directives générales pour la formation de dénominations communes internationales applicables aux substances pharmaceutiques*
View the documentAnexo 1 - Procedimiento de selección de denominaciones comunes internacionales recomendadas para las sustancias farmacéuticas
View the documentAnexo 2 - Principios generales de orientación para formar denominaciones comunes internacionales para sustancias farmacéuticas*
 

Temporary list

The following temporary anatomical therapeutic chemical (ATC) classifications, defined daily doses (DDDs) and alterations were agreed at a meeting of the WHO International Working Group for Drug Statistics Methodology which took place on 26 - 27 May 2003. Comments or objections to the decisions from the meeting should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology, e-mail: whocc@nmd.no.before 15 September 2003. If no objections are received before this date, the new ATC codes and DDDs will be considered final and be included in the January 2004 issue of the ATC index. The inclusion of a substance in the lists does not imply any recommendation of use in medicine or pharmacy.

ATC level

INN/Common name

ATC code

New ATC 5th level codes:

   
 

atomoxetine

N06BA09

 

bemiparin

B01AB12

 

bortezomib

L01XX32

 

celecoxib

L01XX33

 

combinations

B02BC30

 

dextriferron

B03AD04

 

drospirenone and estrogen

G03FA17

 

efalizumab

L04AA21

 

emtricitabine

J05AF09

 

epinastine

S01GX10

 

gemtuzumab

L01XC05

 

levosulpiride

N05AL07

 

lumiracoxib

M01AH06

 

metformin and rosiglitazone

A10BD03

 

minocycline

A01AB23

 

nesiritide

C01DX19

 

norelgestromin and estrogen

G03AA13

 

solifenacin

G04BD08

 

sulfadiazine and tetroxoprim

J01EE06

 

triclabendazole

P02BX04

 

trimegestone and estrogen

G03FA16

ATC code changes

   

Previous:

budesonide

H02AB16

New:

budesonide

A07EA06

Previous:

trospium

A03AB20

New:

trospium

G04BD09

ATC name changes:

   
 

ATC level

ATC code

Previous:

Biguanides and sulfonamides in combination

 

New:

Combinations of oral blood glucose lowering drugs

A10BD

Previous:

Corticosteroids for local use

 

New:

Corticosteroids acting locally

A07EA

Previous:

Psychostimulants and nootropics

 

New:

Psychostimulants, agents used for ADHD and nootropics

N06B

New DDDs:

INN/common name

DDD

Unit

Adm.R

ATC code

adefovir dipivoxil

10

mg

O

J05AF08

alprostadil

0.5

mg

P

C01EA01

bemiparin

2.5

TU

P

B01AB12*

clarithromycin

1

g

P

J01FA09

disulfiram

0.2

g

O

N07BB01

drotrecogin alfa (activated) 40

 

mg

P

B01AD10

eptifibatide

0.2

g

P

B01AC16

ezetimibe

10

mg

O

C10AX09

imiglucerase

300

U

P

A16AB02

minocycline

1

mg

O

A01AB23*

oseltamivir

0.15

g

O

J05AH02

parecoxib

40

mg

P

M01AH04

pegfilgrastim

0.3

mg

P

L03AA13

pegvisomant

10

mg

P

H01AX01

procaine penicillin

0.6

g

P

J01CE09

rosuvastatin

10

mg

O

C10AA07

tadalafil

10

mg

O

G04BE08

teriparatide

20

mcg

P

H05AA02

valdecoxib

10

mg

O

M01AH03

vardenafil

10

mg

O

G04BE09

 

* Temporary ATC code


Change of DDDs

INN/common name

Previous DDD

Unit

Adm.R

New DDD

Unit

Adm.R

ATC code

bezitramide

10

mg

O

15

mg

O

N02AC05

galantamine

24

mg

O

16

mg

O

N06DA04

hydromorphone

4

mg

O

20

mg

O

N02AA03

leflunomide

15

mg

O

20

mg

O

L04AA13

oxycodone

30

mg

O

75

mg

O

N02AA05

repaglinide

6

mg

O

4

mg

O

A10BX02

rofecoxib

12.5

mg

O

25

mg

O

M01AH02

 

to previous section to next section
 

Last updated: May 3, 2013